Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,193 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Safety of Everolimus and Pemetrexed in Lung Cancer Patients

NCT00434174

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Novartis Investigative Site Camperdown, New South Wales, Australia
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Cologne, Germany
View Trial Details
Completed

A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

NCT02082210

Conditions
Adenocarcinoma, Advanced Cancer, Bronchial Neoplasms, +31 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
View Trial Details
Completed

Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer

NCT01772797

Conditions
Anaplastic Lymphoma Kinase (ALK), Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • University of Colorado Dept. of Anschutz Cancer (3) Aurora, Colorado, United States
  • Massachusetts General Hospital Mass General Boston, Massachusetts, United States
  • Fox Chase Cancer Center Fox Chase Cancer (2) Philadelphia, Pennsylvania, United States
  • University of Utah / Huntsman Cancer Institute Huntsman Salt Lake City, Utah, United States
View Trial Details
Completed

Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors

NCT01324479

Conditions
Astrocytoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • University of Chicago SC Chicago, Illinois, United States
  • Karmanos Cancer Institute Wayne St Karmanos Detroit, Michigan, United States
  • Sarah Cannon Research Institute Dept of Onc Nashville, Tennessee, United States
View all 47 locations
View Trial Details
Completed

Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma

NCT00535951

Conditions
Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Medical College of Georgia Augusta, Georgia, United States
  • RUSH Medical Center Chicago, Illinois, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain

NCT02308020

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +28 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California - San Diego La Jolla, California, United States
  • Univ of California San Francisco San Francisco, California, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
View all 44 locations
View Trial Details
Completed

A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors

NCT02222922

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +29 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 17 locations
View Trial Details
Completed

Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.

NCT02292550

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Novartis Investigative Site Boston, Massachusetts, United States
  • Novartis Investigative Site Marseille, France
  • Novartis Investigative Site Bologna, BO, Italy
  • Novartis Investigative Site Rozzano, MI, Italy
View Trial Details

Related conditions